2019
Pre‐transplant alpha‐fetoprotein is associated with post‐transplant hepatocellular carcinoma recurrence mortality
Mahmud N, John B, Taddei T, Goldberg DS. Pre‐transplant alpha‐fetoprotein is associated with post‐transplant hepatocellular carcinoma recurrence mortality. Clinical Transplantation 2019, 33: e13634. PMID: 31177570, PMCID: PMC6635076, DOI: 10.1111/ctr.13634.Peer-Reviewed Original ResearchConceptsHCC recurrenceLiver transplantationAlpha-fetoproteinHepatocellular carcinomaLiver diseaseHepatitis C liver diseaseEnd-stage liver diseaseC liver diseasePre-transplant modelRetrospective cohort studyOrgan Sharing databaseAdult transplant recipientsCox regression analysisTransplant recipientsCohort studySharing databaseMedian timeAFP levelsCox regressionPatient survivalUnited NetworkPoor survivalHigh riskRecurrencePatients
2004
Impact of body mass index on graft failure and overall survival following liver transplant*
Rustgi VK, Marino G, Rustgi S, Halpern MT, Johnson LB, Tolleris C, Taddei TH. Impact of body mass index on graft failure and overall survival following liver transplant*. Clinical Transplantation 2004, 18: 634-637. PMID: 15516235, DOI: 10.1111/j.1399-0012.2004.00141.x.Peer-Reviewed Original ResearchConceptsElevated body mass indexBody mass indexLower body mass indexLikelihood of deathMass indexLiver transplantLiver transplantationGraft failureImpact of BMIHigher body mass indexGraft failure rateNumber of comorbiditiesOrgan Sharing databaseOverall survival rateProportional hazards regressionRisk of deathOverall survivalSharing databaseHazards regressionUnited NetworkRisk factorsBMI valuesPatientsSurvival rateDecreased likelihood
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply